HIV and AIDS Trial, Recruiting NCT06027671 Sponsor: Johns Hopkins University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06027671
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently incarcerated at one of the participating study sites, whether awaiting trial or already sentenced.
  • People who have been diagnosed with HIV and are taking antiretroviral (HIV) medication at the time of joining the study.
  • People whose expected release date or trial date is within three months of joining the study.
  • People who expect to live in an unrestricted (non-prison) setting within the Ekurhuleni, Tshwane, or Johannesburg districts of Gauteng Province after release, and within a reasonable distance of one of the study's support sites (within 20km, a 45-minute travel time, or two local minibus taxi rides).
  • People who are willing to take part in follow-up activities after release and are able to provide contact details for that purpose.

Who may not be able to join:

  • People under 18 years of age.
  • People with a severe cognitive or mental health condition that would prevent them from giving informed consent to participate.
  • People who are otherwise unable to give informed consent to take part in the study.
  • People assessed by correctional facility health staff as needing a higher level of medical care than this type of program can provide (confirm with trial site).
  • People who are not released from the correctional facility during the period when the study program is being delivered.
  • People who are released to an area outside of Gauteng Province.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher Hoffmann, Johns Hopkins School of Medicine

Phone: 4106144257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 November 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

HIV RNA (viral load) suppression at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov